Several UNC Lineberger Comprehensive Cancer Center faculty and trainees were in Washington D.C. Thursday as part of as the Rally for Medical Research, a national campaign that advocates for sustained […]
Channing, Kirsten and Bjoern attended the Pancreatic Cancer Action Network Annual Scientific Meeting in San Diego, CA, August 18-21, 2016. The theme for this meeting was Wage Hope 2020 with […]
Drs. Der, Cox, and Bryant headed to DC June 20 & 21 to support encourage the nations congressmen and women that Pancreatic Cancer research funding needs to be a priority […]
Bjoern Papke, a postdoctoral research fellow in the Der lab, was recently awarded the Otto Hahn Medal from the Max Planck Society in Germany. The Otto Hahn Medal is given […]
As a child, Kirsten Bryant, PhD, used to follow her dad around everywhere. One of his favorite pastimes was working in the yard, and Bryant would be seen pushing a toy wheelbarrow alongside her dad as he tended to their gardens in Womelsdorf, Conn. She would even take naps in the flowerbeds to be near him while he was gardening.
The problem with pancreatic cancer is there aren’t very many simple questions to answer, and I think this discourages people from joining the field because you need to be generating results to get grants.
Dr. Channing Der was honored as this year’s Emmanuel Farber Distinguished Visiting Lecturer. This special talk is a part of the University of Toronto Laboratory Medicine & Pathobiology weekly seminar. […]
PurpleStride is the signature event of the Pancreatic Cancer Action Network. Each year, in communities across the country, tens of thousands of people participate in more than fifty-six PurpleStride events, […]
Researchers from around the country convened in Chapel Hill April 11-12 for UNC Lineberger’s Scientific Symposium to hear the latest research into molecularly targeted treatments for cancer. More than 440 […]
Join participants from across the country – pancreatic cancer survivors, caregivers and volunteers – as we advocate for increased funding for pancreatic cancer research. It’s time to tell Congress that together, we can make the impossible possible for patients everywhere!